Intravenous magnesium sulphate (MgSO4) is an accepted part of the pharmacological management of patients with asthma. There is conflicting information, however, on whether its nebulised form is beneficial. This article describes a case study in which a patient was given intravenous MgSO4. It was suggested by a medical consultant that she could have been given nebulised MgSO4, so a literature review was undertaken to examine its efficacy. The results suggest there is no evidence to support the use of nebulised MgSO4 in the management of patients with asthma.
Emergency Nurse. 24, 7, 28-33. doi: 10.7748/en.2016.e1613Correspondence
This article has been subject to external double-blind peer review and checked for plagiarism using automated softwareConflict of interest
Received: 22 June 2016
Accepted: 25 August 2016
Alternatively, you can purchase access to this article for the next seven days. Buy now